Catherine Sanders | VP, Business Development
Ozette Technologies

Dr. Catherine Sanders is the Vice President of Business Development at Ozette Technologies, a commercial stage company focusing on novel approaches to single cell analysis to accelerate drug development. Prior to joining Ozette, Catherine served as Vice President of Research and Business Development at Adaptive Biotechnologies where she was responsible for establishing partnerships with pharmaceutical companies and key opinion leaders in academia to drive drug discovery and therapeutic development in oncology, hematology, infectious disease, and autoimmunity. Catherine holds a Ph.D. in immunopathology from University of Mississippi Medical Center, an M.S. in pathology from University of Mississippi, and a B.S. in medical technology from Mississippi State University. She completed a post-doctoral fellowship in immunosequencing at Hudson Alpha Institute for Biotechnology.

Appearances:

Main Congress Day 2 - 23rd April @ 13:10

Start-Up Pitches

13:10 - David Nees, VP of Business Development, eEnzyme LLC - 'Cost Effective Viral Neutralization Assays Using Readily Available Virus-Like-Particles'

13:15 - Steven Gold, CEO, Boost Biopharma - 'Safer Vaccines for a Complex World'

13:20 - Pooja Tiwari, Co-Founder & CEO, ARNAV Biotech - 'ARNAV Biotech: Scalable mRNA Vaccines for Neglected and Emerging Viruses'

13:25 - Dr Catherine Sanders, VP of Business Development, Ozette Technologies - 'Revolutionizing Single Cell Immune Profiling and Computational Analysis with Ozette Technologies'

13:30 - Selçuk Koçhan, Co-Founder, MOBIQU - 'Smart Cold Chain: Visibility, Security, and Sustainability in One Solution for Cold Chain'

13:35 - Olli Rundgren, Founder & CEO, Psyon Games - 'Psyon Games – Games for Awareness, Diagnosis, and Therapy'

13:40 - Pamela Housh, Senior Director of Business Development, Eyam Health - 'Innovative Platforms for Next Gen Vaccines’

13:45 - Max Reinertsen, Head of Business Strategy & Operations, Artyc - 'An Option to Modernize Your Cold Chain'

Pooja Tiwari, Co-founder & CEO, ARNAV Biotech